Background: To evaluate the role of partial splenic artery embolization in corpuscular correction in cirrhotic patients. Results: Bleeding tendency was experienced in two thirds of patients (66.7%) and anemia in 63.3%. Splenic size ranged from 14.3 to 22 cm. PV diameter ranged from 11 to 18 mm. The mean platelet at the pre-operative laboratory was 34.9 ± 10.3 × 10 3 , corrected to 137.6 ± 37.1 × 10 3 within 1 month follow-up, and then 140 × 10 3 after 6 months. The mean of RBCs was 3.6 ± 0.3 × 10 6 , then 4 ± 0.5 × 10 6 at 1 month follow-up period. WBCs showed correction at the early post-operative period, 3.3 ± 0.4 × 10 3 , compared to 5.4 ± 1.4 × 10 3 at 1 month. Reduction in splenic size was achieved by 3-6 months. All patients (100%) had post-embolization syndrome. Gelfoam was used in 20 patients, PVA was used in 5 patients, and microspheres were used in 5 patients. Antiviral treatment regimen was started after an adequate rise in corpuscular counts in all patients. Conclusion: Partial splenic artery embolization is an effective alternative method to surgery in treatment of hypersplenism particularly in cirrhotic patients prepared for antiviral treatment with correction of the associated thrombocytopenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.